Dr Danica Brister is completing a fellowship in Severe airways disease and chronic cough at McMaster University. Her current research explores anti- IL5 therapy in eosinophilic bronchitis, and she is currently collaborating with USask faculty in a clinical study exploring the effect of anti-TSLP therapy on airway hyper-responsiveness and mast cell activation in mild asthma. She is interested in the epithelial response to allergic and non-allergic triggers of the sino-pulmonary system, and the clinical consequences of bacteria such as pseudomonas on the respiratory epithelium in asthmatic patients.